- Core One Labs (OTCPK:CLABF) said its unit Vocan Biotechnologies filed patent application for protection of its Biosynthetic Production System for Psilocybin.
- Core One said that with Vocan’s recombinant production system, the subsidiary successfully tested its proof-of-concept for the manufacturing of biosynthetic psilocybin suitable for use in future scale-up and is awaiting patent approval.
- The application includes claims that Vocan’s technology will enable the production of cGMP API grade psilocybin.